Tag: Neurizon Therapeutics Limited

Business

FDA Lifts Clinical Hold on NUZ-001

Highlights: U.S. FDA lifts the Clinical Hold on NUZ‑001, Neurizon®’s lead investigational therapy for ALS Clears the way for entry…